The depletion of substance P by diclofenac in the mouse

European Journal of Pharmacology

Volumn 325, Issue 2-3, 1997, Pages

  Papworth, Jonathan ^a   Colville Nash, Paul ^a   Alam, Chandan ^a   Seed, Michael ^a   Willoughby, Derek ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Analgesia; Diclofenac; Substance P

Indexed keywords

CAPSAICIN; DICLOFENAC; HYALURONIC ACID; SUBSTANCE P;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; DRUG EFFECT; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030917381     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)83070-1     Document Type: Short Survey

References (8)

1. Appleton, I., 1997. NSAIDs and pain. In: Dickson, A., Beeson, J.M. (Eds.), Handbook of Experimental Pharmacology: The Pharmacology of Pain. Springer Verlag, in press.
2. Björkman, R., 1995. Central anti-nociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesth. Scand. 39 (S103), 1-44.
3. Brune, K., Beck, W.S., Geisslinger, G., Menzel-Sogolowek, S., Peskar, B.M., Peskar, B.A., 1991. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 47, 257-261.
4. Dubordieu, C., Dray, F., 1989. Central analgesic action of ketoprofen through prostaglandins and substance P inhibition in rats. In: Proc. 3rd Interscience World Congress on Inflammation, Anti-rheumatics, Analgesics and Immunomodulators, p. 262.
5. Holzer, P., 1991. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurones. Pharmacol. Rev. 43, 143-201.
6. Malcangio, M., Bowery, N.G., 1993. Gamma-aminobutyric acid but not gamma aminobutyric acid receptor activation inhibits electrically evoked substance P-like immunoreactivity release from rat spinal cord in vitro. J. Pharmacol. Exp. Ther. 266, 1490-1496.
7. Moore, A.R., Papworth, J.L., Alam, C.A.S., Seed, M.P., Willoughby, D.A., 1996. Substance P: a target for the actions of hyaluronic acid in combination with diclofenac?. Prog. Rheumatol. 6, 81-85.
8. Sacardote, P., Carrabba, M., Galante, A., Pisati, R., Manfredi, B., Panerai, A.E., 1995. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients -Effect of the nonsteroidal antiinflammatory drugs indomethacin, diclofenac and naproxen. Inflamm. Res. 44, 486-490.